ADIPOQ and metabolic dysfunction-associated steatotic liver disease: All these observations indicate the importance of future research to elucidate whether adiponectin or a combination of adipocytokines in serum is a useful diagnostic marker in NAFLD/NASH as well as in hepatic resections and LT.